RGCC and myeloid sarcoma: For example, CDK2AP1, a cell cycle regulator, was previously identified as an MS risk allele that correlated with reduced RNA expression in lymphoblast cells and peripheral blood mononuclear cells (PBMC’s) (IMSGC, 2010).